Sangamo (SGMO) Posts Wider than Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Sangamo Biosciences Inc. (Nasdaq: SGMO) reported Q1 loss of $0.21, $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $4.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LVMH edges past Q3 revenue estimates as fashion sales slip on China weakness
- PepsiCo (PEP) Tops Q3 EPS by 4c, cuts EPS forecast
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
